Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease

Archives of Neurology

Volumn 56, Issue 6, 1999, Pages 713-718

  Haroutunian, Vahram ^a,b   Purohit, Dushyant P ^a,b   Perl, Daniel P ^a,b   Marin, Deborah ^a,b   Khan, Khalid ^a,b   Lantz, Melinda ^c   Davis, Kenneth L ^a,b   Mohs, Richard C ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Jewish Home and Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NURSING HOME; PRIORITY JOURNAL; RATING SCALE;

EID: 0032995395     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.6.713     Document Type: Article

References (36)

1. Rogers J, Morrison JH. Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer's disease. J Neurosci. 1985;5:2801-2808.
2. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970;11:205-242.
3. Ball M. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. Acta Neuropathol (Berl). 1977; 37:111-118.
4. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
5. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
6. Braak M, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239-259.
7. Braak H, Braak E. Evolution of the neuropatholopy of Alzheimer's disease. Acta Neurol Scand Suppl. 1996;165:3-12.
8. Braak H, Braak E, Bohl J, Reintjes R. Age, neurofibrillary changes, a beta-amyloid and the onset of Alzheimer's disease. Neurosci Lett. 1996;210:87-90.
9. Hyman BT. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiol Aging. 1997;18(suppl 4):S27-S32.
10. The National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 1997(suppl 4);18:S1-S2.
11. Ohm TG, Muller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 1995;64:209-217.
12. Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol. 1994;53:158-164.
13. Ball MJ, Murdoch GH. Neuropathological criteria for the diagnosis of Alzheimer's disease: are we really ready yet? Neurobiol Aging. 1997;18(suppl 4):S4-S12.
14. Xuereb JH, Gertz HJ, Huppert F, Brayne C, Wischik CM. The application of Braak's staging model of Alzheimer-type pathology to neuropathological diagnosis of dementia. Neuropathol Appl Neurobiol. 1995;21:440-459.
15. Price JL. Diagnostic criteria for Alzheimer's disease. Neurobiol Aging. 1997;18 (suppl 4):S67-S70.
16. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging. 1997;18(suppl 4):S85-S88.
17. Mann DMA. A commentary on the diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol Aging. 1997;18(suppl 4):S51-S52.
18. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 1991;12:295-312.
19. Neary D, Snowden JS, Mann DM, et al. Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry. 1986;49:229-237.
20. Wilcock GK, Esiri MM, Plaques, tangles and dementia: a quantitative study. J Neurol Sci. 1982;56:343-356.
21. Bouras C, Hof PR, Morrison JH. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett. 1993;153:131-135.
22. Giannakopoulos P, Hof PR, Giannakopoulos A, Herrmann FR, Michel J, Bouras C. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol. 1995;52:1150-1159.
23. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci. 1968;7:331-356.
24. Dickson DW. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies. Neurobiol Aging. 1997;18(suppl 4):S21-S26.
25. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55:326-335.
26. Haroutunian V, Perl DP, Purohit DP, et al. Regional distribution of neuritic plaques in nondemented elderly and cases of very mild Alzheimer disease. Arch Neurol. 1998;55:1185-1191.
27. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Arch Neurol. 1993;43:2412-2414.
28. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
29. Heyman A, Wilkinson WE, Hurwitz BJ, et al. Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology. 1987;37:980-984.
30. Folstein M, Folstein S, McHugh P. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
31. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
32. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 1988;38:1682-1687.
33. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491-4500.
34. Braak H, Braak E. Staging of Alzheimer's disease: related neurofibrillary changes. Neurobiol Aging. 1995;16:271-278.
35. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572-580.
36. Bierer L, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995;64:749-760.